Foundayo (orforglipron) produces an average weight loss of 7.5%11.2% in 72 weeks (about a year and 45 months), according to a study of adults with obesity
Phase 3 trials were not initiated, and the compound does not hold any approved fat loss indication
If the solution was clear immediately after mixing but becomes cloudy during storage, this indicates bacterial growth or peptide degradation
Kaku, K., Yamada, Y., Watada, H., Abiko, A., Nishida, T., Zacho, J., & Kiyosue, A
Cagrilintide delays gastric emptying, which can slow the absorption of oral medications
It actively binds to growth factor receptors including VEGFR-2 and modulates nitric oxide pathways that control vasodilation and angiogenesis